PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) › Shares OutstandingPROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2010: 91.30M2011: 110.60M2012: 118.43M2013: 159.75M2014: 184.80M2015: 204.98M2016: 364.77M2017: 370.96M2018: 384.61M2019: 389.89M2020: 398.81M2021: 419.45M2022: 419.45M2023: 419.52M2024: 420.28M2025: 420.28M420.28M2010Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025420.28M+0.0%2024420.28M+0.2%2023419.52M+0.0%2022419.45M+0.0%2021419.45M+5.2%2020398.81M+2.3%2019389.89M+1.4%2018384.61M+3.7%2017370.96M+1.7%2016364.77M+78.0%2015204.98M+10.9%2014184.80M+15.7%2013159.75M+34.9%2012118.43M+7.1%2011110.60M+21.1%201091.30M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share